These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 11206674)

  • 1. Sexual activity in hypertensive men treated with valsartan or carvedilol: a crossover study.
    Fogari R; Zoppi A; Poletti L; Marasi G; Mugellini A; Corradi L
    Am J Hypertens; 2001 Jan; 14(1):27-31. PubMed ID: 11206674
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of antihypertensive treatment with valsartan or atenolol on sexual activity and plasma testosterone in hypertensive men.
    Fogari R; Preti P; Derosa G; Marasi G; Zoppi A; Rinaldi A; Mugellini A
    Eur J Clin Pharmacol; 2002 Jun; 58(3):177-80. PubMed ID: 12107602
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of valsartan and atenolol on sexual behavior in hypertensive postmenopausal women.
    Fogari R; Preti P; Zoppi A; Corradi L; Pasotti C; Rinaldi A; Mugellini A
    Am J Hypertens; 2004 Jan; 17(1):77-81. PubMed ID: 14700518
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of indomethacin on the antihypertensive efficacy of valsartan and lisinopril: a multicentre study.
    Fogari R; Zoppi A; Carretta R; Veglio F; Salvetti A;
    J Hypertens; 2002 May; 20(5):1007-14. PubMed ID: 12011663
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and tolerability of combination therapy with valsartan plus hydrochlorothiazide compared with amlodipine monotherapy in hypertensive patients with other cardiovascular risk factors: the VAST study.
    Ruilope LM; Malacco E; Khder Y; Kandra A; Bönner G; Heintz D
    Clin Ther; 2005 May; 27(5):578-87. PubMed ID: 15978306
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antihypertensive efficacy and tolerability of two fixed-dose combinations of valsartan and hydrochlorothiazide compared with valsartan monotherapy in patients with stage 2 or 3 systolic hypertension: an 8-week, randomized, double-blind, parallel-group trial.
    Lacourcière Y; Poirier L; Hebert D; Assouline L; Stolt P; Rehel B; Khder Y
    Clin Ther; 2005 Jul; 27(7):1013-21. PubMed ID: 16154480
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The taboo topic of sexual activity in hypertensive patients. Pioneer study from Pavia proves: potency is not impaired].
    MMW Fortschr Med; 2001 Jun; 143(23):48-9. PubMed ID: 11460426
    [No Abstract]   [Full Text] [Related]  

  • 8. Ambulatory versus clinic blood pressure for the assessment of anti hypertensive efficacy in clinical trials: insights from the Val-Syst Study.
    Palatini P; Dorigatti F; Mugellini A; Spagnuolo V; Varì N; Ferrara R; Bertocchi F
    Clin Ther; 2004 Sep; 26(9):1436-45. PubMed ID: 15531006
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ambulatory blood pressure response to once-daily fimasartan: an 8-week, multicenter, randomized, double-blind, active-comparator, parallel-group study in Korean patients with mild to moderate essential hypertension.
    Lee H; Kim KS; Chae SC; Jeong MH; Kim DS; Oh BH
    Clin Ther; 2013 Sep; 35(9):1337-49. PubMed ID: 23932463
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sexual activity in hypertensive men.
    Della Chiesa A; Pfiffner D; Meier B; Hess OM
    J Hum Hypertens; 2003 Aug; 17(8):515-21. PubMed ID: 12874608
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of valsartan in patients aged > or =65 years with systolic hypertension.
    Neutel JM; Bedigian MP
    Clin Ther; 2000 Aug; 22(8):961-9. PubMed ID: 10972632
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aliskiren, an orally effective renin inhibitor, provides antihypertensive efficacy alone and in combination with valsartan.
    Pool JL; Schmieder RE; Azizi M; Aldigier JC; Januszewicz A; Zidek W; Chiang Y; Satlin A
    Am J Hypertens; 2007 Jan; 20(1):11-20. PubMed ID: 17198906
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and safety of valsartan, an angiotensin II receptor antagonist, in hypertension after renal transplantation: a randomized multicenter study.
    Andrés A; Morales E; Morales JM; Bosch I; Campo C; Ruilope LM;
    Transplant Proc; 2006 Oct; 38(8):2419-23. PubMed ID: 17097955
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Blood pressure lowering efficacy of dual alpha and beta blockers for primary hypertension.
    Wong GW; Laugerotte A; Wright JM
    Cochrane Database Syst Rev; 2015 Aug; 2015(8):CD007449. PubMed ID: 26306578
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Valsartan, a new angiotensin II antagonist: antihypertensive effects over 24 hours.
    Neutel J; Weber M; Pool J; Smith D; Fitzsimmons S; Chiang YT; Gatlin M
    Clin Ther; 1997; 19(3):447-58; discussion 367-8. PubMed ID: 9220209
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sexual function in hypertensive males treated with lisinopril or atenolol: a cross-over study.
    Fogari R; Zoppi A; Corradi L; Mugellini A; Poletti L; Lusardi P
    Am J Hypertens; 1998 Oct; 11(10):1244-7. PubMed ID: 9799042
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and safety of combined use of aliskiren and valsartan in patients with hypertension: a randomised, double-blind trial.
    Oparil S; Yarows SA; Patel S; Fang H; Zhang J; Satlin A
    Lancet; 2007 Jul; 370(9583):221-229. PubMed ID: 17658393
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safety and efficacy of once-daily carvedilol vs twice-daily labetalol in mild to moderate hypertension.
    Ollivier JP; Durier P; Bussiere JL; Gayet JL
    Eur J Clin Pharmacol; 1990; 38 Suppl 2():S164-6. PubMed ID: 1974509
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A home blood pressure monitoring study comparing the antihypertensive efficacy of two angiotensin II receptor antagonist fixed combinations.
    Bobrie G; Delonca J; Moulin C; Giacomino A; Postel-Vinay N; Asmar R;
    Am J Hypertens; 2005 Nov; 18(11):1482-8. PubMed ID: 16280286
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of the angiotensin II antagonist valsartan on sexual function in hypertensive men.
    Düsing R
    Blood Press Suppl; 2003 Dec; 2():29-34. PubMed ID: 14761074
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.